entertainment -WSS

entertainment

author：leisure time 2025-10-01 18:33:51 - browse：2175

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Drugmakers bet big on mRNA for cancer. Why's Biden going in?

entertainment

WSS

Former Pear Therapeutics executives start new VC firm

Why health care costs have stayed mostly flat since 2010

Keeping primary care docs in field isn't impossible, says AAFP CEO

National associations that represent hospice owe an apology

Prime Medicine, Myeloid Therapeutics clash over genome

Virtual care provider acquires bankrupt Pear's prescription apps

explore

entertainment

knowledge

Jerome Adams on the need for new antivirals for Covid

Drinking less cuts risk of oral cavity, esophageal cancer: Report

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FDA advisory panel to debate high blood pressure devices

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Former Pear Therapeutics executives start new VC firm

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Virtual care provider acquires bankrupt Pear's prescription apps

Guidelines to prevent youth baseball injuries need more muscle

Hospital at home shows how to bring innovation to health care

entertainment

Christmas in the PICU brings some surprising joy

California store owner shot dead in dispute over displaying Pride flag: Police

Three trends to watch in biotech in 2024

FDA advisory panel to debate high blood pressure devices

Medicare drug price negotiation hasn't dried up venture capital

HCA sued by state AG for quality issues at Mission Health

focus

entertainment

leisure time

hotspot